SM

Suresh Mamidi

Active Director Director DIN 10591288
DIN 10591288 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Mamidi

Data last updated:

Suresh Mamidi is a Director at Pharma Needs Corporation Private Limited (since 2025) and Designated Partner at Msdc Global Exim Llp (since 2024).

DIN 10591288
Primary Designation Director
First Appointment 15 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 May 20252025Active
Designated Partner15 Apr 20242024Active

Board colleagues of Suresh Mamidi

Directorship timeline

Open interactive timeline →
Pharma Needs Corporation Private Limited
Msdc Global Exim Llp
Premium access

Shareholding and investment profile for Suresh Mamidi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Mamidi

Suresh Mamidi currently holds 2 directorships: Pharma Needs Corporation Private Limited (Director, since 14 May 2025); Msdc Global Exim Llp (Designated Partner, since 15 Apr 2024).

Suresh Mamidi was first appointed on 15 Apr 2024 as Designated Partner at Msdc Global Exim Llp. The most recent appointment on record is 14 May 2025 at Pharma Needs Corporation Private Limited.

The current boards of Suresh Mamidi's companies include Swapna Mamidi (Pharma Needs Corporation Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available